BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16760658)

  • 1. Altered gene expression induced by ionizing radiation and glycolytic inhibitor 2-deoxy-glucose in a human glioma cell line: implications for radio sensitization.
    Heminger K; Jain V; Kadakia M; Dwarakanath B; Berberich SJ
    Cancer Biol Ther; 2006 Jul; 5(7):815-23. PubMed ID: 16760658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
    Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential mechanisms of radiosensitization by 2-deoxy-D-glucose in the monolayers and multicellular spheroids of a human glioma cell line.
    Khaitan D; Chandna S; Arya MB; Dwarakanath BS
    Cancer Biol Ther; 2006 Sep; 5(9):1142-51. PubMed ID: 16855378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
    Dwarakanath BS; Adhikari JS; Jain V
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined radiation and p53 gene therapy of malignant glioma cells.
    Badie B; Goh CS; Klaver J; Herweijer H; Boothman DA
    Cancer Gene Ther; 1999; 6(2):155-62. PubMed ID: 10195882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure.
    Khaitan D; Chandna S; Dwarakanath SB
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
    Kalia VK; Prabhakara S; Narayanan V
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
    Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53.
    Iwadate Y; Mizoe J; Osaka Y; Yamaura A; Tsujii H
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):803-8. PubMed ID: 11395250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polarization of macrophages towards M1 phenotype by a combination of 2-deoxy-d-glucose and radiation: Implications for tumor therapy.
    Farooque A; Afrin F; Adhikari JS; Dwarakanath BS
    Immunobiology; 2016 Feb; 221(2):269-81. PubMed ID: 26597503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose.
    Maehama T; Patzelt A; Lengert M; Hutter KJ; Kanazawa K; Hausen H; Rösl F
    Int J Cancer; 1998 May; 76(5):639-46. PubMed ID: 9610719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cytotoxicity of the glycolytic inhibitor 2-deoxy-D-glucose in isogenic cell lines varying in their p53 status.
    Vibhuti A; Muralidhar K; Dwarakanath BS
    J Cancer Res Ther; 2013; 9(4):686-92. PubMed ID: 24518718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol augments ER stress and the cytotoxic effects of glycolytic inhibition in neuroblastoma by downregulating Akt in a mechanism independent of SIRT1.
    Graham RM; Hernandez F; Puerta N; De Angulo G; Webster KA; Vanni S
    Exp Mol Med; 2016 Feb; 48(2):e210. PubMed ID: 26891914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells.
    Varshney R; Dwarakanath B; Jain V
    Int J Radiat Biol; 2005 May; 81(5):397-408. PubMed ID: 16076755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of radionuclide induced cytotoxicity by 2-deoxy-D-glucose in human tumor cell lines.
    Shrivastava V; Mishra AK; Dwarakanath BS; Ravindranath T
    J Cancer Res Ther; 2006; 2(2):57-64. PubMed ID: 17998676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro.
    Sun S; Han J; Ralph WM; Chandrasekaran A; Liu K; Auborn KJ; Carter TH
    Cell Stress Chaperones; 2004 Mar; 9(1):76-87. PubMed ID: 15270080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC.
    Pang YY; Wang T; Chen FY; Wu YL; Shao X; Xiao F; Huang HH; Zhong H; Zhong JH
    Leuk Lymphoma; 2015 Jun; 56(6):1821-30. PubMed ID: 25219592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense.
    Sharma PK; Varshney R
    Free Radic Res; 2012 Dec; 46(12):1446-57. PubMed ID: 22946929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human glioma cell proliferation by altered Bax/Bcl-2-p53 expression and apoptosis induction by Rhaponticum carthamoides extracts from transformed and normal roots.
    Skała E; Sitarek P; Toma M; Szemraj J; Radek M; Nieborowska-Skorska M; Skorski T; Wysokińska H; Śliwiński T
    J Pharm Pharmacol; 2016 Nov; 68(11):1454-1464. PubMed ID: 27696406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.